As we look to 2022, we identify four REITs with strong potential for a DPU increase.
Browsing: Smart Investing
Despite wars, hyperinflation, venegful enemies, and a despotic dictator, Germany’s stock market has displayed incredible resilience.
Let’s take a look at which blue-chip stocks present the best potential for next year.
The emergence of the Omicron variant has muddied the waters. But the good news for investors is that we are no longer operating without a playbook.
Not everyone has time to spend researching stocks to buy. But there is more than one way to get started investing in the Singapore stock market.
We review the latest corporate updates from three blue-chip companies and a healthcare REIT.
These five stocks have fallen a fair bit from their year-highs. Is it time to revisit them?
As we welcome the New Year and a nascent economic recovery, here are five companies that stand ready to increase their dividends.
Here are four REITs that announced yield-accretive acquisitions that will increase their DPU.
Saving is a good habit but it will not help you to grow your money. Here’s why you should start investing in dividend-paying stocks, too.
China’s regulators have pointedly asked the ride-hailing company to delist from the US. Is this a warning of worse things to come?
Investors who are hunting around the bargain bin for growth stocks may be interested.
Looking for REITs with great yields? Here are three that offer yields of more than 4.5% along with the potential for growth.
You should not discount property stocks when it comes to delivering steady returns. Here’s why.
Nearly three months after we wrote on SPACs, a firm deal may be coming very soon. Here is what you can expect.
Zoom’s share price has fallen hard lately. Here’s why I think long term shareholders shouldn’t be too worried.
If steady and consistent dividends are what you’re looking for, these four stocks should fit the bill.
The almost endless stream of news articles about the latest Omicron variant of COVID-19 is doing my head in. In…
With a double-digit rise in the STI this year thus far, should you be expecting another bountiful year for 2022?
We take a closer look at corporate events for two REITs, a blue-chip company and a healthcare giant.